Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention.
Zhongxiu ChenZheng LiuNan LiRan LiuMiye WangDuolao WangChen LiKai LiFangbo LuoYong HePublished in: Cardiovascular therapeutics (2021)
It seems feasible for patients with thrombocytopenia to receive PCI, but close attention should be paid to advanced thrombocytopenia, the risk of postprocedure bleeding in ACS patients, and the use of more potent P2Y12 inhibitor.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- patients undergoing
- end stage renal disease
- coronary artery disease
- acute myocardial infarction
- st segment elevation myocardial infarction
- atrial fibrillation
- st elevation myocardial infarction
- antiplatelet therapy
- chronic kidney disease
- ejection fraction
- healthcare
- coronary artery bypass grafting
- peritoneal dialysis
- working memory
- emergency department
- prognostic factors
- left ventricular
- adverse drug
- anti inflammatory